<![CDATA[Diagnosis, treatment and full-process surveillance of early rectal cancer]]>
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 03
Abstract
<![CDATA[Early rectal cancer is defined as any size of rectal epithelial tumor with infiltration depth limited to the mucosa and submucosa, regardless of with or without lymph node metastasis. Local resection is one of the main treatment methods for early rectal cancer without local lymph node metastasis. The development of endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), transanal endoscopic microsurgery (TEM), and transanal minimally invasive surgery (TAMIS) has brought more options for the treatment of early rectal cancer. About 8%-12% of early rectal cancer patients have local lymph node metastasis and therefore still require total mesorectal excision (TME). The current guidelines recommend that early rectal cancer with high-risk pathological features requires additional salvage radical surgery. Various minimally invasive and anal sphincter-preserving surgical techniques, such as natural orifice specimen extraction surgery (NOSES), transanal total mesorectal excision (TaTME), intersphincteric resection (ISR), and conformal sphincter-preserving operation (CSPO), have better achieved the goal of anal sphincter preservation and anal function preservation. The overall prognosis of early rectal cancer is good, but full-process surveillance is equally important. With the innovation of early diagnosis, early treatment and full-process surveillance, the development of endoscopic and surgical techniques will further improve the standardization of diagnosis and treatment for early rectal cancer.]]>
Authors and Affiliations
LAN Ping, CHEN Yongle, HE Xiaosheng,
Keywords
Related Articles
- EP ID EP747471
- DOI -
- Views 25
- Downloads 0
Size discrepancy between ultrasonic and pathological measurement of solitary cN0M0 papillary thyroid microcarcinoma
Objective To compare the size discrepancy between ultrasonic and pathological measurement of solitary cN0M0 papillary thyroid microcarcinoma (PTMC), and to explore their correlation with lymph node metastasis. Methods Fr...
Role and possible mechanism of pseudogene FMO6P in inhibiting invasion and metastasis of gastric cancer
[Objective] To determine the expression and clinical significance of pseudogene FMO6P in gastric cancer, and explore its functions and underlying molecular mechanism in regulating the invasion and metastasis of gastric c...
Emerging developments in immune checkpoint inhibitor therapy for gastroenteropancreatic neuroendocrine neoplasm
Immunotherapies targeting immune checkpoints have undergone rapid evolution, and have been preliminary explored in treatment of gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) in recent years. However, their pot...
Advances in diagnosis and molecular detection of EBV-positive gastric cancer and gastric cancer with lymphoid stroma
Epstein-Barr virus-positive gastric cancer, as well as gastric cancer with lymphoid stroma, are the special pathological subtypes of gastric cancer. The histological morphology, immunological and genetic characteristics...
Retrospective study on sugammadex for reversal of neuromuscular blockade after radiofrequency ablation of hepatic carcinoma under general anesthesia
[Objective] To investigate the effect of sugammadex for reversal of neuromuscular blockade postoperatively in the patients with CT guided radiofrequency ablation of hepatic carcinoma under general anesthesia. [Methods] T...